Vireo Growth (VREOF) Current Taxes (2020 - 2025)
Vireo Growth (VREOF) reported Current Taxes of $2.9 million for Q3 2025, up 1427.05% on a YoY basis from $192716.0 in Q3 2024, and down 50.68% sequentially from $6.0 million in Q2 2025.
Vireo Growth (VREOF) Current Taxes (2020 - 2025) Analysis & Trends
Vireo Growth (VREOF) has 6 years of Current Taxes data on file, last reported at $2.9 million in Q3 2025.
- For the quarter ending Q3 2025, Current Taxes rose 1427.05% year-over-year to $2.9 million; the trailing twelve-month figure through Sep 2025 stood at $2.9 million (up 1427.05% YoY), and the FY2024 full-year result was $264518.0, up 21.03% from the prior year.
- Current Taxes fell to $2.9 million in Q3 2025, from $6.0 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $12.6 million in Q3 2023 to a low of $179378.0 in Q2 2024.
- A 5-year average of $4.4 million and a median of $4.7 million in 2022 frame the typical range for Current Taxes.
- Across the five-year window, Current Taxes tumbled 98.47% in 2024 and surged 3226.47% in 2025, its largest moves.
- Tracing VREOF's Current Taxes over 5 years: stood at $5.2 million in 2021, then grew by 18.66% to $6.2 million in 2022, then plunged by 96.46% to $218563.0 in 2023, then rose by 21.03% to $264518.0 in 2024, then soared by 1012.54% to $2.9 million in 2025.
- Business Quant data shows VREOF's Current Taxes at $2.9 million in Q3 2025, $6.0 million in Q2 2025, and $199088.0 in Q1 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 355.15 Mn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 211.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 624.14 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 640.78 Mn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.94 Mn |
| Jun 30, 2025 | 5.97 Mn |
| Mar 31, 2025 | 199,088.00 |
| Dec 31, 2024 | 264,518.00 |
| Sep 30, 2024 | 192,716.00 |
| Jun 30, 2024 | 179,378.00 |
| Mar 31, 2024 | 346,450.00 |
| Dec 31, 2023 | 218,563.00 |
| Sep 30, 2023 | 12.63 Mn |
| Jun 30, 2023 | 8.50 Mn |
| Mar 31, 2023 | 7.97 Mn |
| Dec 31, 2022 | 6.17 Mn |
| Sep 30, 2022 | 6.42 Mn |
| Jun 30, 2022 | 4.65 Mn |
| Mar 31, 2022 | 6.60 Mn |
| Dec 31, 2021 | 5.20 Mn |
| Sep 30, 2021 | 3.00 Mn |
| Jun 30, 2021 | 2.73 Mn |
| Mar 31, 2021 | 8.99 Mn |
| Dec 31, 2020 | 7.23 Mn |